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Abstract
Background: The recent increase in the prevalence of allergic disorders might be a consequence of increased
intake of n-6 polyunsaturated fatty acids (PUFAs) and reduced intake of n-3 PUFAs. The current cross-sectional
study examined the association between intake levels and the prevalence of eczema and rhinoconjunctivitis in
Japanese children.
Methods: Subjects were 23,388 schoolchildren aged 6-15 years residing in Okinawa. The presence of eczema and/
or rhinoconjunctivitis was determined according to the criteria of the International Study of Asthma and Allergies
in Childhood. A brief diet history questionnaire for children and adolescents was administered to acquire
information on dietary factors. Adjustment was made for age, sex, residential municipality, number of siblings,
smoking in the household, body mass index, paternal and maternal history of allergic diseases, and paternal and
maternal educational level.
Results: The prevalences of eczema and rhinoconjunctivitis in the previous 12 months were 7.0% and 8.0%,
respectively. Consumption of PUFAs, n-3 PUFAs, a-linolenic acid, n-6 PUFAs, and linoleic acid was positively
associated with the prevalence of eczema: the adjusted odds ratios (ORs) between extreme quintiles (95%
confidence intervals [CIs], P for trend) were 1.26 (1.07-1.48, 0.04), 1.31 (1.11-1.54, 0.009), 1.31 (1.12-1.55, 0.003), 1.26
(1.07-1.48, 0.01), and 1.27 (1.08-1.49, 0.01), respectively. Arachidonic acid intake was independently inversely related
to eczema: the adjusted OR between extreme quintiles was 0.81 (0.69-0.95, 0.0008). Eczema was not associated
with eicosapentaenoic or docosahexaenoic acid intake, or with the ratio of n-3 to n-6 PUFA intake. Only
arachidonic acid intake was statistically significantly related to the prevalence of rhinoconjunctivitis, showing a clear
inverse linear trend: the adjusted OR between extreme quintiles was 0.86 (0.74-0.997, 0.03).
Conclusions: Consumption of n-3 and n-6 PUFAs, especially a-linolenic acid and linoleic acid, may be positively
associated with eczema. Arachidonic acid intake may be inversely related to eczema and rhinoconjunctivitis.
Background
The prevalences of eczema and rhinoconjunctivitis have
increased rapidly over the last few decades all over the
world [1]. One study of Japanese elementary schoolchil-
dren showed that the lifetime prevalence of eczema
increased from 15.3% in 1985 to 24.2% in 1993 before
decreasing to 16.5% in 2006, while the prevalence of rhi-
nitis increased from 11.6% in 1983 to 24.7% in 2006 [2].
The recent increase in the prevalence of allergic disor-
ders has been hypothesized to be the consequence of
increased intake of n-6 polyunsaturated fatty acids
(PUFAs) and reduced intake of n-3 PUFAs [3]. How-
ever, most of the available epidemiological information
on the relationship between PUFA intake and atopic
eczema or allergic rhinitis has come from studies of
adults. In a study of Norwegian adults, females with
moderate to severe atopic eczema had significantly
lower intakes of eicosapentaenoic and docosahexaenoic
acids compared to a reference group [4]. A significant
inverse association was found between eicosapentaenoic
acid intake and the risk of hay fever in a case-control
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tional study of German adults, a high ratio of n-6 to n-3
PUFA intake was significantly positively related to the
prevalence of atopic eczema, but not hay fever, in
females [6]. The results of a third cross-sectional study
of German adults showed that a higher intake of a-lino-
lenic acid, but not linoleic acid, arachidonic acid, or
eicosapentaenoic acid, was significantly associated with a
lower prevalence of allergic rhinitis [7]. Significant
inverse exposure-response relationships between docosa-
h e x a e n o i ca c i di n t a k ea n dt h ep r e v a l e n c eo fa t o p i c
eczema and allergic rhinitis were found in pregnant
Japanese women [8,9].
Turning to the epidemiological evidence concerning
children, a cohort study showed that n-3 and n-6 PUFA
consumption at 18 months and 3 years was not related
to the risk of eczema in Australian children at the age
of 5 years [10]. In 3 cohort studies among children in
Norway and Sweden, fish intake was significantly inver-
sely related to the risk of eczema and/or allergic rhinitis
[11-13], yet no significant relationship was observed
between fish consumption and eczema or allergic rhini-
tis among children in either a case-control study in Fin-
land or a cross-sectional study in Italy [14,15]. Intake of
margarine, which contains high levels of n-6 PUFAs,
was positively associated with eczema in German chil-
dren in a cohort study [16] and with allergic rhinitis in
2 cross-sectional studies of German children [17,18]. In
the above-mentioned Finnish study, a positive associa-
tion was shown between margarine intake and eczema
but not between margarine intake and allergic rhinitis
[14]. The present cross-sectional study examined the
relationship between intake of specific types of PUFAs
and the prevalence of eczema and rhinoconjunctivitis in
Japanese children using data from the Ryukyus Child
Health Study (RYUCHS).
Methods
Study population
Subjects of the RYUCHS were schoolchildren in 2 of the
41 municipalities in Okinawa Prefecture. Okinawa Pre-
fecture is an island in the southernmost area of Japan,
with a subtropical climate and a total population of
almost 1,385,000. Naha City, the largest city in Okinawa
Prefecture, with a total population of almost 315,000, is
located in the southern region of the island; Nago City,
with a total population of almost 60,000, is located in the
center of the island. All 35 public elementary schools and
17 junior high schools in Naha City and all 17 public ele-
mentary schools and 8 junior high schools in Nago City
participated in the RYUCHS between September 2004
and January 2005. The purpose of the RYUCHS, which
was a cross-sectional survey, was to investigate the asso-
ciations between various selected factors and health
problems in children. A set of 2 self-administered ques-
tionnaires was distributed by teachers to all 38,212
schoolchildren aged 6-15 years. These questionnaires
were completed at home by parents in the case of ele-
mentary schoolchildren and by students themselves and/
or parents in the case of junior high school students.
When research technicians detected missing answers or
illogical data, the teachers returned the questionnaires to
the parents for correction or completion. Finally, 28,885
sets of questionnaires (75.6%) were returned. Excluded
from analysis were 5348 children whose questionnaires
contained missing or illogical data on the variables under
study. We further excluded 149 children with extremely
low or high energy intake (< 2092 kJ/day or > 16,736 kJ/
day) because their estimated dietary intake was likely to
be unreliable. The final analysis included 23,388 children
(61.2%). The RYUCHS was approved by the ethics com-
mittee of the Faculty of Medicine, Fukuoka University.
Written informed consent was obtained from all subjects;
in this survey, the signature of each child/adolescent on
the questionnaires was considered informed consent
made by both the child/adolescent and the parent(s)/
caregiver(s).
Measurements
Dietary habits during the preceding month were
assessed using a brief self-administered diet history
questionnaire (BDHQ) for Japanese children and adoles-
cents [19], which was developed based on comprehen-
sive (16 pages) [20,21] and brief (4 pages) versions of a
validated self-administered diet history questionnaire for
adults. Estimates of daily intake of foods (58 items in
total), energy, and selected nutrients were calculated
using an ad hoc computer algorithm for the BDHQ,
based on the Standard Tables of Food Composition in
Japan [22,23]. The use of dietary supplements, which is
rare in Japan (8% of the general population) [24], was
not incorporated into the analysis. Energy intake was
adjusted by the residual approach for the analyses. The
validity of the BDHQ for children and adolescents using
dietary biomarkers (erythrocyte fatty acids and serum
carotenoids) as the gold standard has been published
elsewhere; briefly, Spearman correlation coefficients in
9 8b o y sa n d8 4g i r l sa g e d1 3 - 1 4y e a r sw e r e0 . 3 5a n d
0.25 for eicosapentaenoic acid, 0.22 and 0.43 for docosa-
hexaenoic acid, 0.21 and 0.13 for a-carotene, 0.23 and
0.33 for b-carotene, and 0.22 and 0.30 for b-cryptox-
anthin, respectively [19]. The BDHQ also elicited infor-
mation on the child’s weight and height. Body mass
index was calculated by dividing self-reported body
weight (kg) by the square of self-reported height (m
2).
The second questionnaire included questions on
symptoms of eczema and rhinoconjunctivitis in the past
12 months based on the International Study of Asthma
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[25,26]. Affirmative answers to the following three ques-
tions were required to confirm the presence of eczema:
“Have you (Has your child) ever had an itchy rash
which was coming and going for at least 6 months?”,
“Have you (Has your child) had this itchy rash at any
time in the last 12 months?” and “Has this itchy rash at
any time affected any of the following places: the folds
of the elbows, behind the knees, in front of the ankles,
under the buttocks, or around the neck, ears, or eyes?”.
Rhinoconjunctivitis was defined as present in the case of
positive responses to the following two questions: “In
the last 12 months, have you (has your child) had a pro-
blem with sneezing or a runny or blocked nose when
you (he/she) did not have a cold or flu?” and “In the
last 12 months, has this nose problem been accompa-
nied by itchy/watery eyes?”. The questionnaire also eli-
cited information on age, sex, number of siblings,
smoking in the household, paternal and maternal history
of asthma, atopic eczema, and allergic rhinitis, and
paternal and maternal educational level. A paternal or
maternal history of asthma, atopic eczema, and allergic
rhinitis was considered positive if the respective parent
had experienced any self-reported symptoms of these
allergic disorders since birth.
Statistical analysis
Intake of selected nutrients was categorized at quintile
points on the basis of the distribution of all study sub-
jects. Age, sex, residential municipality, number of sib-
lings, smoking in the household, body mass index,
paternal and maternal history of allergic diseases, and
paternal and maternal educational level were selected a
priori as potential confounding factors. Age was classi-
fied into 3 categories (6-8, 9-11, and 12-15 years), num-
b e ro fs i b l i n g si n t o4( 0 ,1 ,2 ,a n d3 + ) ,s m o k i n gi nt h e
household into 3 (never, former, and current), and
paternal and maternal educational level into 4 (junior
high school, high school, junior college or vocational
technical school, and university). Body mass index was
used as a continuous variable. Logistic regression analy-
sis was applied to estimate crude odds ratios (ORs) and
95% confidence intervals (CIs) of eczema and rhinocon-
junctivitis according to the quintile of dietary factors
under study, with the lowest quintile as the reference.
Multiple logistic regression analysis was used to control
for potential confounding factors. Trend of association
was assessed by a logistic regression model assigning
consecutive integers to the quintiles of the exposure
variables. Two-sided P-values less than 0.05 were
regarded as statistically significant. All computations
were performed using the SAS software package, version
9.1 (SAS Institute, Inc., Cary, NC, USA).
Results
Data were incomplete for 5497 participants who were
therefore subsequently excluded. Nevertheless, these
excluded participants did provide information that
allowed us to determine some differences between them
and the participants who were included. Compared with
the 5497 excluded subjects, the 23,388 included subjects
were less likely to have no siblings, former smokers in
the household, mothers who were less than 28 years of
age at the time of the child’s birth, and mothers with a
history of asthma and atopic eczema, and were more
l i k e l yt ob ey o u n ga n dt oh a v eap e r s o n a lh i s t o r yo f
eczema and both fathers and mothers with high educa-
tional levels. There was no statistically significant differ-
ence between the excluded participants and study
subjects with regard to the prevalence of rhinoconjuncti-
vitis, sex, paternal history of asthma, atopic eczema, and
allergic rhinitis, or maternal history of allergic rhinitis. It
should be noted, however, that the total of 5497
excluded participants includes 149 participants who
were excluded due to extremely low or high reported
energy intake; when these 149 were excluded from the
excluded participants, study subjects were more likely to
have a high intake of n-3 and n-6 PUFAs in comparison
to the remaining 5348 excluded participants.
Among the 23,388 included subjects, the prevalences
of eczema and rhinoconjunctivitis in the previous 12
months were 7.0% and 8.0%, respectively. Table 1 shows
the distribution of selected variables. About half of the
subjects were exposed to household smoking at the time
of the survey. Mean daily total energy intake and
energy-adjusted consumption of n-3 and n-6 PUFAs
were 8358.9 kJ and 2.0 g and 10.2 g, respectively.
ORs and 95% CIs for the prevalence of eczema and
rhinoconjunctivitis according to dietary intake of specific
types of PUFAs are shown in Table 2. Compared with
PUFA intake in the first quintile, the intake levels in the
third and fifth quintiles were significantly associated
with an increased prevalence of eczema. After adjust-
ment for confounders under study, the positive associa-
tions remained significant, albeit slightly attenuated: the
adjusted OR between extreme quintiles was 1.26 (95%
CI: 1.07-1.48, P for trend = 0.04). Higher intakes of n-3
PUFAs and a-linolenic acid were independently posi-
tively related to the prevalence of eczema: the adjusted
ORs between extreme quintiles were 1.31 (95% CI: 1.11-
1.54, P for trend = 0.009) and 1.31 (95% CI: 1.12-1.55, P
for trend = 0.003), respectively. Significant positive rela-
tionships were also observed between intake levels of n-
6 PUFAs and linoleic acid and the prevalence of eczema:
the adjusted ORs between extreme quintiles were 1.26
(95% CI: 1.07-1.48, P for trend = 0.01) and 1.27 (95%
CI: 1.08-1.49, P for trend = 0.01), respectively. On the
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pendently related to a reduced prevalence of eczema:
the adjusted OR between extreme quintiles was 0.81
(95% CI: 0.69-0.95, P for trend = 0.0008). Such an
inverse association was also detected for rhinoconjuncti-
vitis: the adjusted OR between extreme quintiles was
0.86 (95% CI: 0.74-0.997, P for trend = 0.03). Intakes of
eicosapentaenoic acid and docosahexaenoic acid and the
ratio of n-3 to n-6 PUFA intake were not significantly
related to the prevalence of eczema. No significant
exposure-response associations were found between
intakes of PUFAs, n-3 PUFAs, a-linolenic acid, eicosa-
pentaenoic acid, docosahexaenoic acid, n-6 PUFAs, and
linoleic acid and the ratio of n-3 to n-6 PUFA intake
and the prevalence of rhinoconjunctivitis.
Discussion
The current results show that higher consumption levels
of PUFAs, n-3 PUFAs, a-linolenic acid, n-6 PUFAs, and
linoleic acid are independently associated with an
increased prevalence of eczema whereas intake of ara-
chidonic acid is independently inversely related to the
prevalence of eczema. Consumption of eicosapentaenoic
and docosahexaenoic acid and the ratio of n-3 to n-6
PUFA intake were not associated with eczema. Only
arachidonic acid intake was statistically significantly
related to the prevalence of rhinoconjunctivitis, showing
a clear inverse linear trend. Our results are at variance
with those of an Australian study that reported no asso-
ciations between n-3 and n-6 PUFA intake and child-
hood eczema [10]. Partial agreement was noted with the
results of studies that showed a positive association
between margarine intake and eczema and no relation-
ship between fish intake and allergic rhinitis [14-16], but
our results are at variance with reports of a significant
inverse relationship between fish intake and eczema and
allergic rhinitis [11-13] and with reports of a significant
positive association between margarine intake and aller-
gic rhinitis [17,18]. Previously, using data from the
RYUCHS, we reported that higher intake levels of
PUFAs, n-3 PUFAs, n-6 PUFAs, and linoleic acid were
significantly related to an increased prevalence of
wheeze [27], though we found no associations between
intakes of a-linolenic acid, eicosapentaenoic acid, doco-
sahexaenoic acid, and arachidonic acid, or the ratio of
n - 3t on - 6P U F Ai n t a k e ,a n dw h e e z e[ 2 7 ] .E x p o s u r e -
response relationships were not found between the
intake of any type of PUFA and the prevalence of
asthma [27]. Those findings are in partial agreement
with the current results. With regard to arachidonic
acid, our results are in partial agreement with those
from the KOALA Birth Cohort Study, which showed
that the risk of eczema in the first 12 months of life sig-
nificantly decreased with increasing levels of arachidonic
acid in plasma phospholipids in pregnancy, although
there was no relationship between the arachidonic acid
levels and eczema later in life [28]. The current results
are inconsistent with those of a cross-sectional study
showing a positive association between concentrations
of arachidonic acid in serum phospholipids and hay
Table 1 Distribution of selected characteristics in 23,388
schoolchildren, Ryukyus Child Health Study, Japan
Variable No. (%) or mean
(SD)
Age (% years)
6-8 7063 (30.2)
9-11 8467 (36.2)
12-15 7858 (33.6)
Male sex (%) 11,509 (49.2)
Municipality (%)
Naha City 19,206 (82.1)
Nago City 4182 (17.9)
Siblings (%)
0 2144 (9.2)
1 7864 (33.6)
2 8823 (37.7)
3+ 4557 (19.5)
Smoking in household (%)
Never 10,083 (43.1)
Former 2381 (10.2)
Current 10,924 (46.7)
Paternal history of allergic diseases (%)
1 5495 (23.5)
Maternal history of allergic diseases (%)
1 6612 (28.3)
Paternal educational level (%)
Junior high school 1813 (7.8)
High school 10,394 (44.4)
Junior college or vocational technical school 3484 (14.9)
University 7697 (32.9)
Maternal educational level (%)
Junior high school 1173 (5.0)
High school 10,330 (44.2)
Junior college or vocational technical
school
9788 (41.9)
University 2097 (9.0)
Body mass index (kg/m
2) 17.8 (3.1)
Daily nutrient intake
2
Total Energy (kJ) 8358.9 (2253.2)
Polyunsaturated fatty acids (g) 14.3 (3.1)
n-3 Polyunsaturated fatty acids (g) 2.0 (0.6)
a-Linolenic acid (18:3 n-3) (g) 1.6 (0.5)
Eicosapentaenoic acid (20:5 n-3) (g) 0.11 (0.09)
Docosahexaenoic acid (22:6 n-3) (g) 0.27 (0.15)
n-6 Polyunsaturated fatty acids (g) 10.2 (2.7)
Linoleic acid (18:2 n-6) (g) 10.0 (2.7)
Arachidonic acid (20:4 n-6) (g) 0.12 (0.04)
1 Asthma, atopic eczema, or allergic rhinitis.
2 Nutrient intake was adjusted for total energy intake using the residual method.
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Page 4 of 9Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for eczema and rhinoconjunctivitis in relation to dietary
intake of polyunsaturated fatty acids in 23,388 schoolchildren, Ryukyus Child Health Study, Japan
Eczema Rhinoconjunctivitis
Variable
1 Prevalence
(%)
Crude OR (95%
CI)
Adjusted OR (95%
CI)
2
Prevalence
(%)
Crude OR (95%
CI)
Adjusted OR (95%
CI)
2
Polyunsaturated fatty acids
Q1 (10.7) 6.1 1.00 1.00 8.8 1.00 1.00
Q2 (12.8) 6.8 1.13 (0.96-1.34) 1.10 (0.94-1.31) 7.6 0.86 (0.74-0.99) 0.86 (0.74-0.999)
Q3 (14.2) 7.7 1.29 (1.10-1.51) 1.23 (1.05-1.45) 7.2 0.81 (0.69-0.94) 0.81 (0.70-0.95)
Q4 (15.6) 6.5 1.08 (0.92-1.28) 1.02 (0.86-1.21) 7.9 0.89 (0.77-1.03) 0.89 (0.77-1.04)
Q5 (18.0) 7.9 1.33 (1.13-1.56) 1.26 (1.07-1.48) 8.6 0.98 (0.85-1.13) 0.97 (0.83-1.12)
P for trend 0.005 0.04 0.96 0.83
n-3 Polyunsaturated fatty acids
Q1 (1.3) 5.8 1.00 1.00 8.1 1.00 1.00
Q2 (1.7) 6.9 1.20 (1.02-1.42) 1.16 (0.98-1.37) 8.2 1.01 (0.87-1.17) 1.01 (0.87-1.17)
Q3 (2.0) 7.4 1.30 (1.10-1.53) 1.22 (1.04-1.45) 7.1 0.87 (0.75-1.01) 0.87 (0.74-1.01)
Q4 (2.3) 6.9 1.21 (1.02-1.42) 1.12 (0.94-1.32) 8.1 1.00 (0.86-1.16) 0.99 (0.85-1.15)
Q5 (2.8) 7.9 1.40 (1.19-1.64) 1.31 (1.11-1.54) 8.6 1.07 (0.93-1.24) 1.05 (0.90-1.22)
P for trend 0.0003 0.009 0.45 0.63
a-Linolenic acid (18:3 n-3)
Q1 (1.0) 5.8 1.00 1.00 8.6 1.00 1.00
Q2 (1.3) 6.7 1.17 (0.99-1.39) 1.14 (0.96-1.35) 8.0 0.93 (0.80-1.08) 0.93 (0.80-1.08)
Q3 (1.5) 7.5 1.32 (1.12-1.56) 1.25 (1.06-1.47) 7.2 0.82 (0.71-0.95) 0.82 (0.71-0.96)
Q4 (1.8) 7.1 1.24 (1.05-1.46) 1.15 (0.97-1.36) 8.1 0.94 (0.81-1.09) 0.94 (0.81-1.09)
Q5 (2.2) 8.0 1. 41 (1.20-1.66) 1.31 (1.12-1.55) 8.2 0.95 (0.82-1.10) 0.93 (0.80-1.08)
P for trend < 0.0001 0.003 0.57 0.41
Eicosapentaenoic acid (20:5 n-3)
Q1 (0.03) 6.4 1.00 1.00 8.3 1.00 1.00
Q2 (0.07) 6.8 1.06 (0.90-1.25) 1.04 (0.88-1.23) 7.8 0.94 (0.81-1.10) 0.95 (0.82-1.11)
Q3 (0.09) 7.1 1.10 (0.94-1.30) 1.07 (0.91-1.26) 7.6 0.92 (0.79-1.06) 0.91 (0.78-1.06)
Q4 (0.12) 7.5 1.18 (1.002-1.38) 1.15 (0.98-1.35) 7.5 0.90 (0.78-1.05) 0.90 (0.77-1.05)
Q5 (0.21) 7.2 1.13 (0.96-1.33) 1.12 (0.95-1.31) 8.9 1.09 (0.94-1.26) 1.10 (0.95-1.27)
P for trend 0.06 0.09 0.41 0.42
Docosahexaenoic acid (22:6 n-3)
Q1 (0.13) 6.9 1.00 1.00 8.5 1.00 1.00
Q2 (0.20) 6.6 0.95 (0.81-1.12) 0.94 (0.80-1.11) 7.6 0. 89 (0.76-1.03) 0. 90 (0.77-1.05)
Q3 (0.24) 7.5 1.08 (0.93-1.27) 1.04 (0.88-1.21) 7.6 0.88 (0.76-1.02) 0.86 (0.74-0.998)
Q4 (0.30) 7.0 1.01 (0.86-1.18) 0.99 (0.84-1.16) 7.9 0.92 (0.79-1.06) 0.92 (0.79-1.06)
Q5 (0.43) 7.0 1.01 (0.86-1.19) 1.01 (0.86-1.18) 8.5 1.00 (0.87-1.16) 1.00 (0.86-1.16)
P for trend 0.67 0.75 0.85 0.92
n-6 Polyunsaturated fatty acids
Q1 (7.1) 6.1 1.00 1.00 8.6 1.00 1.00
Q2 (8.8) 6.8 1.12 (0.95-1.32) 1.07 (0.91-1.27) 7.9 0.91 (0.78-1.05) 0.91 (0.78-1.05)
Q3 (10.1) 7.2 1.19 (1.01-1.40) 1.14 (0.96-1.34) 7.7 0.88 (0.76-1.02) 0.90 (0.77-1.05)
Q4 (11.3) 7.0 1.15 (0.97-1.35) 1.08 (0.91-1.27) 7.5 0.86 (0.74-1.001) 0.87 (0.75-1.02)
Q5 (13.5) 8.0 1.33 (1.13-1.56) 1.26 (1.07-1.48) 8.5 0.99 (0.86-1.15) 0.98 (0.85-1.14)
P for trend 0.001 0.01 0.71 0.68
Linoleic acid (18:2 n-6)
Q1 (6.9) 6.1 1.00 1.00 8.6 1.00 1.00
Q2 (8.7) 6.8 1.12 (0.95-1.32) 1.08 (0.91-1.27) 7.9 0.91 (0.78-1.05) 0.91 (0.79-1.06)
Q3 (9.9) 7.2 1.20 (1.02-1.41) 1.14 (0.97-1.34) 7.5 0.86 (0.74-1.002) 0.88 (0.76-1.03)
Q4 (11.1) 6.9 1.13 (0.96-1.33) 1.06 (0.90-1.26) 7.5 0.86 (0.74-0.999) 0.87 (0.75-1.02)
Q5 (13.3) 8.0 1.34 (1.14-1.57) 1.27 (1.08-1.49) 8.6 1.00 (0.87-1.16) 1.00 (0.86-1.15)
P for trend 0.001 0.01 0.77 0.76
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tionship between arachidonic acid and allergic disorders
might change according to the timing of the exposure:
an inverse relationship may exist starting in utero and
continuing through childhood, whereas a positive rela-
tionship may exist in adulthood.
Linoleic acid can be converted to arachidonic acid,
which is usually the major substrate for eicosanoid
synthesis [30]. Eicosanoids, which consist of prosta-
glandins, thromboxanes, leukotrienes, and other oxi-
dized derivatives, are generated from arachidonic acid
by cyclooxygenase and lipoxygenase enzymes [30].
Some eicosanoids are implicated in clinical manifesta-
tions of allergic disorders, although individual prosta-
glandins might augment or inhibit inflammation
related to allergic reactions, depending upon their spe-
cific action [30,31]. One current paradigm is that pros-
taglandin D2,p r o s t a g l a n d i nF 2a, and thromboxane A2
increase allergic inflammation whereas prostaglandin
E2 and prostaglandin I2 inhibit allergen-induced
inflammatory responses [31]. Given the positive rela-
tionships between linoleic acid intake and the produc-
tion of prostaglandin D2, prostaglandin F2a,a n d
thromboxane A2, the current results showing an asso-
ciation of linoleic acid intake with an increased preva-
lence of eczema might be considered reasonable,
although no relationship between linoleic acid intake
and rhinoconjunctivitis was shown. On the other hand,
higher arachidonic acid intake may have led to
increased production of prostaglandin E2 and prosta-
glandin I2, with a consequent decrease in eczema and
rhinoconjunctivitis in the subjects studied.
Long chain n-3 PUFAs inhibit arachidonic acid incor-
poration into cell membranes and inhibit arachidonic
acid metabolism to eicosanoids [30]. Given that higher
a-linolenic acid intake especially inhibits the production
of prostaglandin E2 and prostaglandin I2, the present
results concerning a-linolenic acid intake and eczema
also might be reasonable although a null relationship
between such intake and rhinoconjunctivitis was found.
In Japan, fish intake is high. The mean values for daily
intake of eicosapentaenoic and docosahexaenoic acids in
this population were 0.11 g and 0.27 g, respectively. In
many parts of Europe, the daily intake of eicosapentae-
noic acid + docosahexaenoic acid by adults is < 100 mg
[32]. In a nested case-control study of Australian chil-
dren that showed a significant positive association
between the ratio of n-6 to n-3 PUFAs in the diet and
the risk of asthma [33], the mean value of daily n-3
PUFA intake and the ratio of n-3 to n-6 PUFA intake
among 169 controls were 1.05 g and 0.065, respectively;
these values were much lower than the corresponding
figures in this study (2.03 g and 0.199, respectively).
Therefore, protective associations of n-3 PUFA intake
and the ratio of n-3 to n-6 PUFA intake with eczema
and rhinoconjunctivitis might be detected when con-
sumption of n-3 PUFAs is very low. Alternatively,
unrecognized active agents in fish might have counter-
acted the benefit of marine-origin n-3 PUFAs in eczema
and rhinoconjunctivitis. For example, methylmercury
and dioxins are accumulated in fish and shellfish
through the marine food web. One study has found a
significant correlation between fish consumption and
hair mercury levels, reporting that hair mercury levels
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for eczema and rhinoconjunctivitis in relation to dietary
intake of polyunsaturated fatty acids in 23,388 schoolchildren, Ryukyus Child Health Study, Japan (Continued)
Arachidonic acid (20:4 n-6)
Q1 (0.07) 7.9 1.00 1.00 8.9 1.00 1.00
Q2 (0.10) 7.5 0.95 (0.81-1.10) 0.92 (0.78-1.07) 7.8 0.87 (0.75-1.01) 0.88 (0.76-1.02)
Q3 (0.12) 6.7 0.83 (0.71-0.98) 0.80 (0.68-0.94) 8.2 0.92 (0.79-1.06) 0.91 (0.78-1.05)
Q4 (0.14) 6.3 0.79 (0.67-0.92) 0.76 (0.65-0.89) 7.5 0.84 (0.72-0.97) 0.83 (0.72-0.97)
Q5 (0.17) 6.6 0.83 (0.71-0.97) 0.81 (0.69-0.95) 7.8 0.87 (0.75-1.01) 0.86 (0.74-0.997)
P for trend 0.002 0.0008 0.05 0.03
n-3/n-6 Polyunsaturated fatty acid
ratio
Q1 (0.17) 6.0 1.00 1.00 7.4 1.00 1.00
Q2 (0.18) 7.1 1.20 (1.02-1.41) 1.17 (0.99-1.38) 7.8 1.06 (0.91-1.23) 1.05 (0.90-1.23)
Q3 (0.20) 7.0 1.18 (0.997-1.39) 1.14 (0.96-1.34) 8.1 1.10 (0.94-1.28) 1.07 (0.92-1.25)
Q4 (0.21) 7.6 1.28 (1.09-1.51) 1.21 (1.03-1.42) 8.0 1.08 (0.93-1.26) 1.04 (0.89-1.21)
Q5 (0.23) 7.2 1.21 (1.03-1.43) 1.17 (0.99-1.38) 8.7 1.19 (1.03-1.38) 1.16 (0.99-1.35)
P for trend 0.02 0.07 0.03 0.11
1 Quintile medians in g/day adjusted energy intake using the residual method are given in parentheses, except for the ratio of n-3 to n-6 polyunsaturated fatty
acids, which was based on crude intake in g/day.
2 Adjustment for age, sex, residential municipality, number of siblings, smoking in the household, body mass index, paternal and maternal history of allergic
diseases, and paternal and maternal educational level.
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Page 6 of 9were much higher in Japanese women residing in
Canada than in Canadian women [34].
Eggs, meat, fish, milk, and sweets are major sources of
arachidonic acid intake among Japanese people [35].
Meat, milk, and sweets are also major sources of trans
fatty acid intake among Japanese people [36]. Arachido-
nic acid intake may be to some extent correlated with
trans fatty acid intake. In this study, data on trans fatty
acid intake were not available because the Standard
Tables of Food Composition in Japan do not include
information on trans fatty acids. In the KOALA Birth
Cohort Study, higher concentrations of trans fatty acids
from a rumenic source in human breast milk were asso-
ciated with a lower risk of eczema at 2 years of age [37].
In contrast, an ecological study using data from the
International Study of Asthma and Allergies in Child-
hood showed positive relationships between trans fatty
acid intake and the prevalences of asthma, eczema, and
rhinoconjunctivitis [38].
The current study had methodological advantages.
Study subjects were homogeneous in terms of age and
geographical background. That the study included a
large number of both subjects and confounders was
likely to minimize problems due to small sample size,
inadequate data on potential confounders, and reduced
statistical power. However, residual confounding could
not be ruled out. In particular, no adjustment was made
for data on allergen exposure and the home environ-
ment. The core questions used to assess the outcomes
under study had been validated by the International
Study of Asthma and Allergies in Childhood phase-I
study, but validation tests of the questions had not been
performed in this population. Moreover, no attempt was
made to ascertain outcome status through reviews of
medical records.
Other weaknesses include the fact that dietary data
were obtained through a self-administered dietary
assessment questionnaire (i.e., BDHQ). Because actual
dietary habits were not observed, the results should be
interpreted with caution, although the validity of the
BDHQ appears reasonable, as described above. The esti-
mates of consumption of specific types of PUFAs
derived from the BDHQ might not reflect long-term
intake by subjects. Nevertheless, subjects with eczema or
rhinoconjunctivitis were likely to be unaware of the pos-
sible ill effects of PUFA intake. The consequence would
have been underestimation in our results. Information
on dietary supplements was not available in the present
study; their use, however, is uncommon in Japan [24].
The BDHQ was answered by parents in the case of ele-
mentary schoolchildren and by students and/or parents
in the case of junior high school students. Dietary data
on children and adolescents is, in the main, prone to
reporting error [39]. We cannot predict whether
possible selective misreporting of dietary intake would
systematically deflate or inflate the estimates of these
dietary variables. In any case, random misclassification
in our study was likely, and it probably weakened the
evidence for any true relationships. Information on self-
reported body weight and height was not validated, and
thus body mass index might have been biased.
Only 61.2% of the eligible subjects were included in
the current analysis, suggesting that selection bias might
have been inevitable. In fact, as mentioned above, there
was a significant difference between the excluded parti-
cipants and study subjects with regard to several factors.
Okinawa has unique characteristics regarding its geo-
graphical location, as it is located at the southern extre-
mity of Japan, is close to Taiwan, and is the only
prefecture in Japan situated in a subtropical climate
zone. Moreover, Okinawa is less developed than the
mainland because it only reverted to Japanese adminis-
tration in 1972. The distribution of a variety of environ-
mental factors including diet and socioeconomic status
as well as allergy in Okinawa is likely to differ from that
in the mainland of Japan. For example, according to the
criteria of the International Study of Asthma and Aller-
gies in Childhood, the prevalences of eczema and rhino-
conjunctivitis in the previous 12 months were 14.5%
and 23.9%, respectively, among Japanese adolescents in
Suita City, an urban area in the mainland [40]. Because
Japanese cedar pollinosis is a major public health pro-
blem in the mainland of Japan, this finding with regard
to rhinoconjunctivitis is not unexpected. Because Oki-
nawa has comparatively few Japanese cedars, however,
people in Okinawa are not as likely to experience rhino-
conjunctivitis. We should, therefore, be cautious in gen-
eralizing the present results to Japanese children in the
mainland. Another limitation is that we could not take
clustering of conditions within families into considera-
tion, as no information was available on familial rela-
tionships among the subjects. This lack of data might
influence relationships of interest.
Conclusion
This is the first epidemiological study among children to
report that consumption of n-3 and n-6 PUFAs, especially
a-linolenic acid and linoleic acid, is significantly positively
associated with the prevalence of eczema. Also, new evi-
dence is presented showing significant inverse relation-
ships between arachidonic acid intake and the prevalence
of eczema and rhinoconjunctivitis. Because different
mechanisms might be involvedi nt h em a n i f e s t a t i o no f
eczema and that of rhinoconjunctivitis, there might also
be differences in the detrimental effects of a-linolenic acid
and linoleic acid. Owing to the cross-sectional nature of
this study, which eliminates any causal inferences, and the
incompleteness of the biological explanations for these
Miyake et al. BMC Public Health 2011, 11:358
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Page 7 of 9associations, further investigations are needed to ascertain
whether the relationships observed in this study are repli-
cated in other populations, especially in populations with
high n-3 PUFA intake.
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